Patents by Inventor Egil Lien

Egil Lien has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9138468
    Abstract: Described herein are microorganisms that are modified so that they have an increased ability to be recognized by the innate immune system of a eukaryote, relative to an unmodified microorganism. A microorganism may be a gram-negative bacterium that has been modified to produce high potency lipopolysaccharide, e.g., Yersinia pestis expressing LpxL. Such modified microorganisms may be used as vaccines for protection against an infection by the unmodified microorganism. They may also be used as delivery vehicles of one or more heterologous antigens, e.g., antigens from pathogens or those associated with a hyperproliferative eukaryotic cell.
    Type: Grant
    Filed: June 17, 2014
    Date of Patent: September 22, 2015
    Assignee: UNIVERSITY OF MASSACHUSETTS
    Inventors: Egil Lien, Jon D. Goguen
  • Publication number: 20140328880
    Abstract: Described herein are microorganisms that are modified so that they have an increased ability to be recognized by the innate immune system of a eukaryote, relative to an unmodified microorganism. A microorganism may be a gram-negative bacterium that has been modified to produce high potency lipopolysaccharide, e.g., Yersinia pestis expressing LpxL. Such modified microorganisms may be used as vaccines for protection against an infection by the unmodified microorganism. They may also be used as delivery vehicles of one or more heterologous antigens, e.g., antigens from pathogens or those associated with a hyperproliferative eukaryotic cell.
    Type: Application
    Filed: June 17, 2014
    Publication date: November 6, 2014
    Inventors: Egil Lien, Jon D. Goguen
  • Patent number: 8802419
    Abstract: Described herein are microorganisms that are modified so that they have an increased ability to be recognized by the innate immune system of a eukaryote, relative to an unmodified microorganism. A microorganism may be a gram-negative bacterium that has been modified to produce high potency lipopolysaccharide, e.g., Yersinia pestis expressing LpxL. Such modified microorganisms may be used as vaccines for protection against an infection by the unmodified microorganism. They may also be used as delivery vehicles of one or more heterologous antigens, e.g., antigens from pathogens or those associated with a hyperproliferative eukaryotic cell.
    Type: Grant
    Filed: March 2, 2006
    Date of Patent: August 12, 2014
    Assignee: University of Massachusetts
    Inventors: Egil Lien, Jon D. Goguen
  • Publication number: 20100112002
    Abstract: Described herein are microorganisms that are modified so that they have an increased ability to be recognized by the innate immune system of a eukaryote, relative to an unmodified microorganism. A microorganism may be a gram-negative bacterium that has been modified to produce high potency lipopolysaccharide, e.g., Yersinia pestis expressing LpxL. Such modified microorganisms may be used as vaccines for protection against an infection by the unmodified microorganism. They may also be used as delivery vehicles of one or more heterologous antigens, e.g., antigens from pathogens or those associated with a hyperproliferative eukaryotic cell.
    Type: Application
    Filed: March 2, 2006
    Publication date: May 6, 2010
    Applicant: University of Massachusetts
    Inventors: Egil Lien, Jon D. Goguen
  • Publication number: 20030170241
    Abstract: The present invention relates to the use of an immunomodulating agent, in particular intravenous immunoglobulin (IVIG), in the manufacture of a medicament for use in the treatment of non-viral or non-autoimmune induced heart disorders or non-viral or non-autoimmune associated phases of heart disorders or the symptoms associated therewith. Particular heart disorders to be treated are selected from the group comprising chronic CHF, chronic (stable) angina pectoris and acute coronary syndromes. Pharmaceutical compositions for use in the treatment of such disorders comprising immunomodulating agents are also provided.
    Type: Application
    Filed: February 20, 2003
    Publication date: September 11, 2003
    Inventors: Pal Aukrust, Stig Froland, Svein Simonsen, Halfdan Aass, Jan Fjeld, Arne Andreassen, Halfdan Ihlen, John Kjekshus, Sigurd Nitter-Hauge, Thor Ueland, Lars Gullestad, Egil Lien
  • Patent number: 5477813
    Abstract: The invention provides a plant for the storage of fish and shellfish that includes a net cage for submerging in a body of water. The cage includes a floor section, surrounding walls with bottom ends thereof attached to a perimeter of the floor section, and an upper roof section of netting with bottom ends thereof attached to top ends of the walls. The roof conforms to a frustoconical shape when in use and includes a central buoyant member in an upper end thereof. In use, the roof extends slackly from the central buoyant member to the points of attachment at the surrounding walls. The surrounding walls are vertically supported by a plurality of buoyant bodies attached to the upper edge of the walls. The entire cage is supported in water by a support section supplied with a buoyant element. The support section is, in turn, held in place by an anchoring section that includes a plurality of substantially parallel vertical cables that are anchored to bottom.
    Type: Grant
    Filed: June 10, 1994
    Date of Patent: December 26, 1995
    Assignee: Sinvent A/S
    Inventor: Egil Lien